BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10080909)

  • 1. Thrombopoietin signal transduction: studies from cell lines and primary cells.
    Drachman JG; Rojnuckarin P; Kaushansky K
    Methods; 1999 Mar; 17(3):238-49. PubMed ID: 10080909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.
    Nagata Y; Nagahisa H; Nagasawa T; Todokoro K
    Leukemia; 1997 Apr; 11 Suppl 3():435-8. PubMed ID: 9209416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel MPL point mutation resulting in thrombopoietin-independent activation.
    Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
    Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
    Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
    Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
    Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
    Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin and its receptor.
    Wendling F; Vainchenker W
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
    Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
    Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
    Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
    Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
    Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
    Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation.
    Alexander WS; Maurer AB; Novak U; Harrison-Smith M
    EMBO J; 1996 Dec; 15(23):6531-40. PubMed ID: 8978680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction.
    Gurney AL; de Sauvage FJ
    Stem Cells; 1996; 14 Suppl 1():116-23. PubMed ID: 11012211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin signal transduction requires functional JAK2, not TYK2.
    Drachman JG; Millett KM; Kaushansky K
    J Biol Chem; 1999 May; 274(19):13480-4. PubMed ID: 10224114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
    Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
    Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
    Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
    Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J; Sabath DF; Kuter DJ
    Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.